Jane Street Group LLC Sells 416,310 Shares of Senseonics Holdings, Inc. (NYSE:SENS)

Jane Street Group LLC lowered its stake in shares of Senseonics Holdings, Inc. (NYSE:SENS) by 82.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 90,060 shares of the company’s stock after selling 416,310 shares during the quarter. Jane Street Group LLC’s holdings in Senseonics were worth $31,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in SENS. FMR LLC grew its holdings in Senseonics by 48,267.2% in the third quarter. FMR LLC now owns 168,318 shares of the company’s stock worth $59,000 after purchasing an additional 167,970 shares during the last quarter. GSA Capital Partners LLP acquired a new stake in shares of Senseonics in the 3rd quarter worth $117,000. Symmetry Partners LLC purchased a new position in Senseonics during the 3rd quarter worth $164,000. Finally, Cubist Systematic Strategies LLC increased its position in Senseonics by 25.9% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock valued at $166,000 after buying an additional 85,501 shares in the last quarter. Institutional investors own 12.36% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. StockNews.com started coverage on Senseonics in a report on Thursday, December 26th. They issued a “sell” rating for the company. HC Wainwright reaffirmed a “buy” rating and issued a $2.00 price objective on shares of Senseonics in a research report on Friday, November 15th.

Senseonics Price Performance

NYSE SENS opened at $0.88 on Friday. The company has a market cap of $520.91 million, a price-to-earnings ratio of -6.73 and a beta of 0.64. The company has a debt-to-equity ratio of 59.17, a current ratio of 2.47 and a quick ratio of 2.38. The stock’s fifty day moving average price is $0.42 and its 200 day moving average price is $0.40. Senseonics Holdings, Inc. has a 1 year low of $0.25 and a 1 year high of $0.91.

Insider Buying and Selling at Senseonics

In other Senseonics news, CFO Frederick T. Sullivan bought 124,933 shares of Senseonics stock in a transaction that occurred on Thursday, December 12th. The stock was purchased at an average price of $0.38 per share, with a total value of $47,474.54. Following the completion of the acquisition, the chief financial officer now directly owns 2,478,844 shares in the company, valued at approximately $941,960.72. This trade represents a 5.31 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Timothy T. Goodnow purchased 315,000 shares of the stock in a transaction on Tuesday, December 10th. The stock was acquired at an average cost of $0.31 per share, for a total transaction of $97,650.00. Following the completion of the acquisition, the chief executive officer now owns 11,310,355 shares of the company’s stock, valued at $3,506,210.05. The trade was a 2.86 % increase in their position. The disclosure for this purchase can be found here. Company insiders own 3.60% of the company’s stock.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.